Bayer shares fall after Monsanto weedkiller judgment; FDA approves first birth-control app to be marketed as contraception method; Regulators okay landmark RNAi-based therapy.
from Most popular articles from Medical Marketing and Media https://ift.tt/2MnGIok
No comments:
Post a Comment